• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖个体中的微小泡性脂肪变性:非酒精性脂肪性肝病严重程度的组织学标志物。

Microvesicular Steatosis in Individuals with Obesity: a Histological Marker of Non-alcoholic Fatty Liver Disease Severity.

机构信息

Department of Surgery, School of Medical Sciences, State University of Campinas (UNICAMP), Rua Alexander Fleming, S/No, Cidade Universitária Zeferino Vaz, SP, CEP 13085-000, Campinas, Brazil.

School of Medicine, Pontíficia Universidade Católica de Campinas (PUCCAMP), Campinas, Brazil.

出版信息

Obes Surg. 2023 Mar;33(3):813-820. doi: 10.1007/s11695-023-06467-9. Epub 2023 Jan 24.

DOI:10.1007/s11695-023-06467-9
PMID:36694089
Abstract

BACKGROUND

In non-alcoholic fatty liver disease (NAFLD), steatosis can manifest through two distinct forms: macrovesicular (macroS) and microvesicular (microS).

OBJECTIVE

To investigate the prevalence of microS and its association with biochemical parameters and NAFLD-related histological findings in individuals with obesity.

METHODS

This is an observational retrospective cross-sectional study, enrolling individuals who underwent bariatric surgery and liver biopsy at a university hospital. A 1:2 propensity matching was performed to pair microS with isolated macroS; this matching enrolled variables "age," "gender," "body mass index (BMI)," and "obesity-associated medical problems." Clinical, biochemical, and histopathological aspects were then analyzed and compared.

RESULTS

Of 115 participants, 88.7% were female; average age was 40.5 ± 5 years and mean BMI was 37.9 ± 3.3 kg/m. Steatosis occurred in 82.6% (67.8% isolated macroS and 14.8% microS). MicroS is significantly associated with higher levels of alanine aminotransferase (ALT) (39.8 ± 26.4 vs. 26.7 ± 17.5; p = 0.04) and glucose (103.8 ± 52.6 vs. 83.3 ± 10.8; p = 0.03) and higher frequencies of moderate to severe macroS (41.2% vs. 2.0%; p < 0.001), portal fibrosis (100% vs. 50%; p < 0.001), perisinusoidal fibrosis (100% vs. 55.9%; p < 0.001), lobular inflammation (100% vs. 41.1%; p < 0.001), and portal inflammation (100% vs. 41.1%; p < 0.001). An independently positive association was observed between intensities of microS and macroS (p < 0.001).

CONCLUSION

MicroS is significantly associated with higher levels of ALT and glucose and higher frequencies of moderate to severe macroS, hepatocellular ballooning, portal fibrosis, perisinusoidal fibrosis, lobular inflammation, and portal inflammation. These findings indicate that microS could be considered a reliable histological marker of NAFLD severity.

摘要

背景

在非酒精性脂肪性肝病(NAFLD)中,脂肪变性可以通过两种不同的形式表现出来:大泡性(macrovesicular,macroS)和小泡性(microvesicular,microS)。

目的

研究肥胖个体中小泡性脂肪变性的患病率及其与生化参数和与 NAFLD 相关的组织学发现的关系。

方法

这是一项观察性回顾性病例对照研究,纳入了在一所大学医院接受减肥手术和肝活检的患者。采用 1:2 倾向评分匹配将 microS 与孤立的 macroS 进行配对;该匹配纳入了变量“年龄”、“性别”、“体重指数(BMI)”和“肥胖相关的医疗问题”。然后分析和比较了临床、生化和组织病理学方面。

结果

在 115 名参与者中,88.7%为女性;平均年龄为 40.5±5 岁,平均 BMI 为 37.9±3.3kg/m2。脂肪变性发生率为 82.6%(单纯 macroS 为 67.8%,microS 为 14.8%)。microS 与丙氨酸氨基转移酶(ALT)水平升高显著相关(39.8±26.4 与 26.7±17.5;p=0.04)和葡萄糖(103.8±52.6 与 83.3±10.8;p=0.03),且中重度 macroS 的频率更高(41.2%与 2.0%;p<0.001)、门脉纤维化(100%与 50%;p<0.001)、窦周纤维化(100%与 55.9%;p<0.001)、小叶炎症(100%与 41.1%;p<0.001)和门脉炎症(100%与 41.1%;p<0.001)。microS 与 macroS 之间存在独立的正相关关系(p<0.001)。

结论

microS 与 ALT 和葡萄糖水平升高以及中重度 macroS、肝细胞气球样变、门脉纤维化、窦周纤维化、小叶炎症和门脉炎症的频率较高显著相关。这些发现表明,microS 可以作为 NAFLD 严重程度的可靠组织学标志物。

相似文献

1
Microvesicular Steatosis in Individuals with Obesity: a Histological Marker of Non-alcoholic Fatty Liver Disease Severity.肥胖个体中的微小泡性脂肪变性:非酒精性脂肪性肝病严重程度的组织学标志物。
Obes Surg. 2023 Mar;33(3):813-820. doi: 10.1007/s11695-023-06467-9. Epub 2023 Jan 24.
2
Association of Histopathological and Biochemical Aspects of NAFLD With the Severity of Liver Fibrosis in Individuals With Obesity: Cross-sectional Study.非酒精性脂肪性肝病的组织病理学和生物化学特征与肥胖个体肝纤维化严重程度的相关性:横断面研究。
Obes Surg. 2024 May;34(5):1569-1574. doi: 10.1007/s11695-024-07180-x. Epub 2024 Mar 19.
3
Application of Scores Assessing Histological Activity and Estimated Long-Term Risk Analysis of Hepatic Decompensation of Non-Alcoholic Fatty Liver Disease in Individuals Undergoing Bariatric Surgery.应用评分评估非酒精性脂肪性肝病患者行减重手术后的肝组织学活动和估计长期肝失代偿风险。
Obes Surg. 2023 May;33(5):1580-1586. doi: 10.1007/s11695-023-06568-5. Epub 2023 Apr 1.
4
Microvesicular steatosis: a missed item in the management of nonalcoholic fatty liver disease?微泡性脂肪变性:非酒精性脂肪性肝病管理中被遗漏的一项?
Acta Gastroenterol Belg. 2020 Oct-Dec;83(4):565-570.
5
Correlation Between Anthropometric Measurements and Non-alcoholic Fatty Liver Disease in Individuals With Obesity Undergoing Bariatric Surgery: Cross-Sectional Study.肥胖患者接受减重手术后人体测量学指标与非酒精性脂肪性肝病的相关性:横断面研究。
Obes Surg. 2021 Aug;31(8):3675-3685. doi: 10.1007/s11695-021-05470-2. Epub 2021 May 12.
6
Identification of Predictors of Non-alcoholic Steatohepatitis and Its Severity in Individuals Undergoing Bariatric Surgery.识别接受减重手术患者非酒精性脂肪性肝炎及其严重程度的预测因子。
Obes Surg. 2024 Feb;34(2):456-466. doi: 10.1007/s11695-023-06986-5. Epub 2023 Dec 14.
7
Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.接受减肥手术的重度肥胖南印度患者中非酒精性脂肪性肝病的患病率及预测因素
Obes Surg. 2015 Nov;25(11):2078-87. doi: 10.1007/s11695-015-1655-1.
8
Is Helicobacter pylori infection associated with non-alcoholic fatty liver disease in individuals undergoing bariatric surgery? Cross-sectional study.肥胖症患者行减重手术后,幽门螺杆菌感染是否与非酒精性脂肪性肝病相关?横断面研究。
Sao Paulo Med J. 2023 Apr 7;141(5):e2022517. doi: 10.1590/1516-3180.2022.0517.R1.14122022. eCollection 2023.
9
Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.病态肥胖的肝脏组织病理学:其他形式慢性肝病的并发情况。
Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392.
10
Impact of pre-operative weight loss on non-alcoholic fatty liver disease histopathology and insulin resistance in individuals undergoing bariatric surgery: a propensity matched cross-sectional comparison.术前体重减轻对接受减重手术的个体非酒精性脂肪性肝病组织病理学和胰岛素抵抗的影响:倾向评分匹配的横断面比较。
Sao Paulo Med J. 2023 Jun 9;142(1):e2022663. doi: 10.1590/1516-3180.2022.0663.R1.24042023. eCollection 2024.

引用本文的文献

1
Helicobacter hepaticus promotes hepatic steatosis through CdtB-induced mitochondrial stress and lipid metabolism reprogramming.肝螺杆菌通过CdtB诱导的线粒体应激和脂质代谢重编程促进肝脂肪变性。
Nat Commun. 2025 Aug 26;16(1):7954. doi: 10.1038/s41467-025-63351-z.
2
Lipid Microparticle-Based Phantoms Modeling Hepatic Steatosis for the Validation of Quantitative Imaging Techniques.基于脂质微粒的肝脂肪变性模型体模用于定量成像技术的验证
Small Methods. 2025 Aug;9(8):e2500043. doi: 10.1002/smtd.202500043. Epub 2025 Apr 25.
3
Short-Term Evolution of MASLD Following Roux-en-Y Gastric Bypass: A Focus on Fibrotic MASH.

本文引用的文献

1
Trajectory of NAFLD characteristics after Roux-en-Y gastric bypass: a five-year historical cohort study.Roux-en-Y 胃旁路术后非酒精性脂肪性肝病特征的演变轨迹:一项为期五年的历史队列研究。
Sao Paulo Med J. 2022 Nov-Dec;140(6):739-746. doi: 10.1590/1516-3180.2021.0828.07012022.
2
NASH Presence is Associated with a Lower Weight Loss One and 2 Years After Bariatric Surgery in Women with Severe Obesity.NASH 存在与女性严重肥胖患者减肥手术后 1 年和 2 年后的体重减轻相关。
Obes Surg. 2022 Oct;32(10):3313-3323. doi: 10.1007/s11695-022-06175-w. Epub 2022 Jul 6.
3
Roux-en-Y Gastric Bypass as a Treatment for Hepatic Iron Overload: An Exploratory Study.
Roux-en-Y胃旁路术后代谢相关脂肪性肝病的短期演变:聚焦纤维化代谢相关脂肪性肝病
Obes Surg. 2025 Mar;35(3):926-933. doi: 10.1007/s11695-025-07688-w. Epub 2025 Jan 27.
4
Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance.肠 FGF15 调节胆汁酸和胆固醇代谢,但不调节葡萄糖和能量平衡。
JCI Insight. 2024 Apr 8;9(7):e174164. doi: 10.1172/jci.insight.174164.
5
Association of Histopathological and Biochemical Aspects of NAFLD With the Severity of Liver Fibrosis in Individuals With Obesity: Cross-sectional Study.非酒精性脂肪性肝病的组织病理学和生物化学特征与肥胖个体肝纤维化严重程度的相关性:横断面研究。
Obes Surg. 2024 May;34(5):1569-1574. doi: 10.1007/s11695-024-07180-x. Epub 2024 Mar 19.
6
Fibrotic NASH in Individuals with Obesity: a Cross-sectional Analysis of the Prevalence of this Significant Milestone of Disease Progression and Accuracy of a Non-invasive Marker for its Screening.肥胖人群中的纤维化 NASH:这一疾病进展重要里程碑的患病率的横断面分析,及其非侵入性标志物筛查的准确性。
Obes Surg. 2024 Feb;34(2):389-395. doi: 10.1007/s11695-023-06998-1. Epub 2023 Dec 19.
7
Involvement of Lipophagy and Chaperone-Mediated Autophagy in the Pathogenesis of Non-Alcoholic Fatty Liver Disease by Regulation of Lipid Droplets.脂滴调控的脂噬和伴侣介导的自噬在非酒精性脂肪肝病发病机制中的作用。
Int J Mol Sci. 2023 Nov 2;24(21):15891. doi: 10.3390/ijms242115891.
Roux-en-Y胃旁路术治疗肝铁过载:一项探索性研究。
Obes Surg. 2022 Jul;32(7):2438-2444. doi: 10.1007/s11695-022-06103-y. Epub 2022 May 11.
4
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?非酒精性脂肪性肝病(NAFLD)。线粒体作为治疗的靶点和参与者?
Int J Mol Sci. 2021 May 20;22(10):5375. doi: 10.3390/ijms22105375.
5
Microvesicular steatosis: a missed item in the management of nonalcoholic fatty liver disease?微泡性脂肪变性:非酒精性脂肪性肝病管理中被遗漏的一项?
Acta Gastroenterol Belg. 2020 Oct-Dec;83(4):565-570.
6
Development and Validation of a Predictive Model of Success in Bariatric Surgery.发展和验证肥胖症手术成功的预测模型。
Obes Surg. 2021 Mar;31(3):1030-1037. doi: 10.1007/s11695-020-05103-0. Epub 2020 Nov 14.
7
Baseline Presence of NAFLD Predicts Weight Loss after Gastric Bypass Surgery for Morbid Obesity.非酒精性脂肪性肝病的基线存在情况可预测病态肥胖患者胃旁路手术后的体重减轻。
J Clin Med. 2020 Oct 26;9(11):3430. doi: 10.3390/jcm9113430.
8
Recent Epidemiology of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的最新流行病学。
Gut Liver. 2021 Mar 15;15(2):206-216. doi: 10.5009/gnl20127.
9
Molecular Characterization of Microvesicular and Macrovesicular Steatosis Shows Widespread Differences in Metabolic Pathways.微泡性和大泡性脂肪变性的分子特征显示代谢途径存在广泛差异。
Lipids. 2019 Jan;54(1):109-115. doi: 10.1002/lipd.12121. Epub 2019 Feb 5.
10
Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review.非酒精性脂肪性肝病与减肥手术:一项综合综述
Sao Paulo Med J. 2017 May-Jun;135(3):277-295. doi: 10.1590/1516-3180.2016.0306311216. Epub 2017 May 29.